 Antibiotic therapy intra-abdominal sepsis elderly experience ticarcillin clavulanic acid Age major factor outcome patients intra-abdominal sepsis Poor outcome patients number physiologic immunologic changes treatment intra-abdominal sepsis special risks elderly Standard aminoglycosides substantial risk nephrotoxicity elderly patients Alternatives aminoglycoside-containing regimens desirable intra-abdominal infections multiple pathogens aerobic anaerobic polymicrobial nature intra-abdominal sepsis antimicrobial chemotherapy effective broad range organisms past several years host new antibiotics used combination drugs potential aminoglycosides many patients intra-abdominal sepsis agent ticarcillin clavulanate potassium active wide spectrum aerobic anaerobic pathogens prospective open label trial ticarcillin clavulanate gentamicin clindamycin sample size small meaningful statistical comparisons efficacy safety regimens effective general prolonged administration aminoglycosides treatment intra-abdominal sepsis elderly initial empiric use aminoglycosides